Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase NA 1Phase 4 1

Status

Completed 3Terminated 2Recruiting 2Not yet recruiting 2

Sponsor Class

OTHER 82INDUSTRY 9OTHER_GOV 3UNKNOWN 2NETWORK 1

Study Type

Interventional 7Observational 2

Sponsor

Cancer Type

Genitourinary 13Gastrointestinal 9Breast 9Other hematologic neoplasm 7Thoracic 6Plasma cell 6Lymphoid 5Tumor-Agnostic 4Head & Neck 4Gynecologic 4CNS 4Dermatologic 2Sarcoma 1Other solid neoplasm 1Myeloid 1Classical hematology 1

Conditions

Breast Neoplasms 9Neoplastic Cells, Circulating 1Neoplasms 1Neoplasm Metastasis 1Medication Adherence 1

Interventions

Trastuzumab 242Paclitaxel 223Fulvestrant 196Capecitabine 182Docetaxel 164Letrozole 142pembrolizumab 115Carboplatin 100exemestane 98Gemcitabine 98Cyclophosphamide 92palbociclib 86Anastrozole 83pertuzumab 78Lapatinib 73Bevacizumab 71ribociclib 68130-nm albumin-bound paclitaxel 66abemaciclib 59eribulin 58Doxorubicin 55Vinorelbine 51Injections 47Ado-Trastuzumab Emtansine 47Tamoxifen 45Everolimus 44Albumin-Bound Paclitaxel 44atezolizumab 35trastuzumab deruxtecan 34Nivolumab 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

9 trials
RecentStart dateEnrollment
INDUSTRY × Standard of Care × Breast × Clear all
NCT04567420 2026-06-03

DARE

Criterium, Inc.

Phase 2 Recruiting
70 enrolled
Breast

Breast Neoplasms

NCT07563595 2026-05-04

ELENI

iOMEDICO AG

Not yet recruiting
500 enrolled
Breast

Breast Neoplasms

NCT03778931 2025-09-15

EMERALD

Stemline Therapeutics, Inc.

Phase 3 Completed
478 enrolled 16 charts 1 FDA
Breast

Breast Neoplasms

NCT06309615 2025-05-29

PDxBRUTILITY

Precise Dx, Inc.

Not yet recruiting
300 enrolled
Breast

Breast Neoplasms

NCT06989450 2025-05-25

Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer

Sidekick Health

Phase NA Recruiting
140 enrolled
Breast

Breast Neoplasms, Neoplasms, Medication Adherence

NCT00556374 2023-07-27

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

Amgen

Phase 3 Completed
3,420 enrolled 19 charts
Breast

Breast Neoplasms

NCT03202446 2018-02-23

Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer

Eske Corporation S.A.C

Phase 3 Terminated
18 enrolled
Breast

Breast Neoplasms

NCT00977379 2016-11-15

XERAD

Hoffmann-La Roche

Phase 2 Terminated
24 enrolled 20 charts
Breast

Breast Neoplasms

NCT01129336 2014-05-20

MACS1295

Novartis

Phase 4 Completed
44 enrolled 10 charts
Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡